North Carolina Clinical Research
Private Company
Funding information not available
Overview
North Carolina Clinical Research is a well-established, private clinical research organization (CRO) site that has conducted over 650 studies since its founding in 1994. It operates a services-based business model, generating revenue by contracting with pharmaceutical and biotechnology sponsors to conduct Phase I-IV outpatient clinical trials, primarily in respiratory therapeutics. With a core team of approximately 13 professionals boasting over 250 combined years of experience, NCCR has built a strong reputation for patient-centric care and operational reliability in the Raleigh-Durham research hub. Its success is driven by a steady pipeline of sponsor contracts and a dedicated base of repeat volunteer participants.
Technology Platform
Operational clinical trial execution platform specializing in outpatient studies, including patient recruitment/retention systems, respiratory-specific diagnostic equipment, and regulatory-compliant data management infrastructure.
Opportunities
Risk Factors
Competitive Landscape
NCCR competes with other independent clinical research sites, large national and global CRO networks, and academic medical centers conducting trials. Its differentiation lies in its deep, niche expertise in respiratory trials, long-standing community presence for patient recruitment, and emphasis on patient-centric care within a smaller, focused operational model.